Release of neurotransmitters in the locus coeruleus

Progress in Neurobiology

Volumn 56, Issue 2, 1998, Pages 237-267

  Singewald, Nicolas ^a   Philippu, Athineos ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ADRENALIN; ASPARTIC ACID; CATECHOLAMINE; DOPAMINE; EXCITATORY AMINO ACID; GLUTAMIC ACID; GLYCINE; NEUROTRANSMITTER; NORADRENALIN; OPIATE; SEROTONIN;

ANIMAL TISSUE; BLOOD PRESSURE REGULATION; BRAIN PERFUSION; CARDIOVASCULAR RESPONSE; DRUG WITHDRAWAL; LOCUS CERULEUS; MICRODIALYSIS; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NEUROTRANSMITTER UPTAKE; NOCICEPTION; NOISE; NONHUMAN; POTENTIOMETRY; PRIORITY JOURNAL; RAT; REVIEW; STIMULUS SECRETION COUPLING;

EID: 0031689935     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(98)00039-2     Document Type: Article

References (328)

1. Abercrombie E. D., Jacobs B. L. Microinjected clonidine inhibits noradrenergic neurons of the locus coeruleus in freely moving cats. Neurosci. Lett. 76:1987;203-208.
2. Abercrombie E. D., Jacobs B. L. Single-unit response of noradrenergic neurons in the locus coeruleus of freely moving cats. 1. Acutely presented stressful and nonstressful stimuli. J. Neurosci. 7:1987;2837-2843.
3. G-nitro-L-arginine methyl ester. Life Sci. 52:1993;245-249.
4. Adams R. N. In vivo electrochemical measurements in the CNS. Prog. Neurobiol. 35:1990;297-311.
5. Adell A., Carceller A., Artigas F. In vivo brain dialysis study of the somatodendritic release of serotonin in the raphe nuclei of the rat: effects of 8-hydroxy-2-(di-n-propylamino)tetralin. J. Neurochem. 60:1993;1673-1681.
6. Aghajanian G. K. Tolerance of locus coeruleus neurons to morphine and suppression of withdrawal response by clonidine. Nature. 267:1978;186-188.
7. Aghajanian G. K., Cedarbaum J. M., Wang R. Y. Evidence for norepinephrine-mediated collateral inhibition of locus coeruleus neurons. Brain Res. 136:1977;570-577.
8. Aghajanian G. K., Kogan J. H., Moghaddam B. Opiate withdrawal increases glutamate and aspartate efflux in the locus coeruleus: an in vivo microdialysis study. Brain Res. 636:1994;126-130.
9. Akaoka H., Aston-Jones G. Opiate withdrawal-induced hyperactivity of locus coeruleus neurons is substantially mediated by augmented excitatory amino acid input. J. Neurosci. 11:1991;3830-3839.
10. Amaral D. G., Sinnamon H. M. The locus coeruleus: neurobiology of a central noradrenergic nucleus. Prog. Neurobiol. 9:1977;147-196.
11. Arnold, F. (1851) Handbuch der Anatomie des Menschen, Vol. 2. Berder, Freiburg.
12. Asnis G. M., Wetzler S., Sanderson W. C., Kahn R. S., van-Praag H. M. Functional interrelationship of serotonin and norepinephrine: cortisol response to MCPP and DMI in patients with panic disorder, patients with depression, and normal control subjects. Psychiat. Res. 43:1992;65-76.
13. Aston-Jones G., Bloom F. E. Norepinephrine-containing locus coeruleus neurons in behaving rats exhibit pronounced responses to nonnoxious environmental stimuli. J. Neurosci. 1:1981;887-900.
14. Aston-Jones G., Bloom F. E. Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J. Neurosci. 1:1981;876-886.
15. Aston-Jones, G., Shipley, M. T., Ennis, M., Williams, J. T. and Pieribone, V. A. (1990) Restricted afferent control of locus coeruleus neurons revealed by anatomical, physiological and pharmacological studies. In: The Pharmacology of Noradrenaline in the Central Nervous System, pp. 187-247. Eds. C. A. Marsden and D. J. Heal. Oxford University Press, Oxford.
16. Aston-Jones G., Shipley M. T., Chouvet G., Ennis M., Van Bockstaele E., Pieribone V., Shiekhattar R., Akaoka H., Drolet G., Astier B., Charlety P., Valentino R. J., Williams J. T. Afferent regulation of locus coeruleus neurons: anatomy, physiology and pharmacology. Prog. Brain Res. 88:1991;47-75.
17. Aston-Jones, G., Valentino, R. J., van Bockstaele, E. J. and Meyerson, A. T. (1994) Locus coeruleus, stress, and PTSD: neurobiological and clinical parallels. In: Catecholamine Function in Posttraumatic Stress Disorder: Emerging Concepts, pp. 17-62. Ed. M. M. Murburg. American Psychiatric Press, Washington, D.C.
18. Aston-Jones, G., Shipley, M. T. and Grzanna, R. (1995) The locus coeruleus, A5 and A7 noradrenergic cell groups. In: The Rat Nervous System, pp. 183-213. Ed. G. Paxinos. Academic Press, San Diego, CA.
19. Aston-Jones G., Rajkowski J., Kubiak P., Valentino R. J., Shipley M. T. Role of the locus coeruleus in emotional activation. Prog. Brain Res. 107:1996;379-402.
20. Baranowski R., Lynn B., Pini A. The effects of locally applied capsaicin on conduction in cutaneous nerves in four mammalian species. Br. J. Pharmacol. 89:1986;267-276.
21. Barnes, C. D. and Pompeiano, O. (1991) Neurobiology of the locus coeruleus. Prog. Brain Res. 88.
22. Basbaum A. I. Descending control of pain transmission: possible serotonergic-enkephalinergic interactions. Adv. Exp. Med. Biol. 133:1981;177-189.
23. Benveniste H. Brain microdialysis. J. Neurochem. 52:1989;1667-1679.
24. Benveniste H., Hansen A. J., Ottosen N. S. Determination of brain interstitial concentrations by microdialysis. J. Neurochem. 52:1989;1741-1750.
25. Berod A. M., Chat M., Paut L., Tappaz M. Catecholaminergic and GABAergic anatomical relationship in the rat substantia nigra, locus coeruleus, hypothalamic median eminence: immunocytochemical visualization of biosynthetic enzymes on serial semithin plastic-embedded sections. J. Histochem. Cytochem. 32:1984;1331-1338.
26. Bhaskaran D., Freed C. R. Changes in neurotransmitter turnover in locus coeruleus produced by changes in arterial blood pressure. Brain Res. Bull. 21:1988;191-199.
27. Bigazzi R., Kogosov E., Campese V. M. Altered norepinephrine turnover in the brain of rats with chronic renal failure. J. Am. Soc. Nephrol. 4:1994;1901-1907.
28. Bläsig J., Herz A., Reinhold K., Zieglgänsberger S. Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rat. Psychopharmacology. 33:1973;19-38.
29. Blessing W. W., Chalmers J. P., Howe P. R. C. Distribution of catecholamine-containing cell bodies in the rabbit central nervous system. J. Comp. Neurol. 179:1978;407-424.
30. Blizard D. A. The locus ceruleus: a possible neural focus for genetic differences in emotionality. Experientia. 44:1988;491-495.
31. Bobker D. H., Williams J. T. Serotonin agonists inhibit synaptic potentials in the rat locus ceruleus in vitro via 5-hydroxytryptamine1A and 5-hydroxytryptamine1B receptors. J. Pharmacol. Exp. Ther. 250:1989;37-43.
32. Borsody M. K., Weiss J. M. Influence of corticotropin-releasing hormone on electrophysiologic activity of locus coeruleus neurons. Brain Res. 724:1996;149-168.
33. Bosker F., Klompmakers A., Westenberg H. Extracellular 5-hydroxytryptamine in median raphe nucleus of the conscious rat is decreased by nanomolar concentrations of 8-hydroxy-2-(di-n-propylamino)tetralin and is sensitive to tetrodotoxin. J. Neurochem. 63:1994;2165-2171.
34. Bosker F., Vrinten D., Klompmakers A., Westenberg H. The effect of a 5-HT1A receptor agonist and antagonist on the 5-hydroxytryptamine release in the central nucleus of the amygdala: a microdialysis study with flesinoxan and WAY 100635. Naunyn-Schmiedeberg's Arch. Pharmac. 355:1997;347-353.
35. Bousquet P., Feldman J., Tibirica E., Bricca G., Greney H., Dontenwill M., Stutzmann J., Belcourt A. Imidazoline receptors. A new concept in central regulation of the arterial blood pressure. Am. J. Hypertension. 5:1992;47-50.
36. 3H]idazoxan in rat brain. J. Pharmac. Exp. Ther. 241:1987;1079-1091.
37. Brady L. S. Stress, antidepressant drugs, and the locus coeruleus. Brain Res. Bull. 35:1994;545-556.
38. Bremner J. D., Krystal J. H., Southwick S. M., Charney D. S. Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies. Synapse. 23:1996;28-38.
39. Britton K. T., Svensson T., Schwartz J., Bloom F. E., Koob G. F. Dorsal noradrenergic bundle lesions fail to alter opiate withdrawal or suppression of opiate withdrawal by clonidine. Life Sci. 34:1984;133-139.
40. Brownstein, M. and Palkovits, M. (1984) Catecholamines, serotonin, acetylcholine and γ-aminobutyric acid in the rat brain: biochemical studies. In: Handbook of Chemical Neuroanatomy, Eds. A. Bjorklund and T. Hokfeld, 2, Classical Transmitters in the CNS, Part 1. Elsevier Science, Amsterdam.
41. Brun P., Suaud-Chagny M. F., Lachuer J., Gonon F., Buda M. Catecholamine metabolism in locus coeruleus neurons: a study of its activation by sciatic nerve stimulation in the rat. Eur. J. Neurosci. 3:1991;397-406.
42. Buda, M. and Gonon, F. (1987) Study of brain noradrenergic neurons by use of in vivo voltammetry. In: Voltammetry in the Neurosciences, pp. 239-272. Ed. J. B. Justice Jr. Humana Press, Clifton, NJ.
43. Buda M., De Simoni G., Gonon F., Pujol J.-F. Catecholamine metabolism in the rat locus coeruleus as studied by in vivo differential pulse voltammetry.I. nature and origin of contributors to the oxidation current at +0.1 V. Brain Res. 273:1983;197-206.
44. Butler P. D., Weiss J. M., Stout J. C., Nemeroff C. B. Corticotropin-releasing factor produces fear-enhancing and behavioural activating effects following infusion into the locus coeruleus. J. Neurosci. 10:1990;176-183.
45. Caldecott-Hazard S., Morgan D. G., DeLeon-Jones F., Overstreet D. H., Janowsky D. Clinical and biochemical aspects of depressive disorders: II. Transmitter/receptor theories. Synapse. 9:1991;251-301.
46. Cappendijk S. L. T., Duval S. Y., de Vries R., Dzoljic M. R. Comparative study of normotensive and hypertensive nitric oxide synthase inhibitors on morphine withdrawal syndrome in rats. Neurosci. Lett. 183:1995;67-70.
47. Cedarbaum J. M., Aghajanian G. K. Noradrenergic neurons of the locus coeruleus: inhibition by epinephrine and activation by the α-antagonist piperoxane. Brain Res. 112:1976;413-419.
48. Cedarbaum J. M., Aghajanian G. K. Catecholamine receptors on locus coeruleus neurons: pharmacological characterization. Eur. J. Pharmac. 44:1977;375-385.
49. Cedarbaum J. M., Aghajanian G. K. Afferent projections to the locus coeruleus as determined by a retrograde tracing technique. J. Comp. Neurol. 178:1978;1-16.
50. Cedarbaum J. M., Aghajanian G. K. Activation of locus coeruleus neurons by peripheral stimuli: modulation by a collateral inhibitory mechanism. Life Sci. 23:1978;1383-1392.
51. Chalmers J., Pilowsky P. Brainstem and bulbospinal neurotransmitter systems in the control of blood pressure. J. Hypertens. 9:1991;675-695.
52. Chamba G., Weissmann D., Rousset C., Renaud B., Pujol J. F. Distribution of alpha-1 and alpha-2 binding sites in the rat locus coeruleus. Brain Res. Bull. 26:1991;185-193.
53. Chan J. Y. H., Jang S.-F., Chan S. H. H. Inhibition by locus coeruleus on the baroreceptor reflex response in the rat. Neurosci. Lett. 144:1992;225-228.
54. Chan R. K., Sawchenko P. E. Spatially and temporally differentiated patterns of c-fos expression in brainstem catecholaminergic cell groups induced by cadiovascular challenges in the rat. J. Comp. Neurol. 348:1994;433-460.
55. Charney, D. S., Bremner, J. D. and Redmond D. E. Jr (1995) Noradrenergic neural substrates for anxiety and fear: clinical associations based on preclinical research. In: Psychopharmacology: The Fourth Generation of Progress, pp. 387-395. Eds F. E. Bloom and D. J. Kupfer. Raven Press, New York.
56. Chen S. Y., Wu W. C., Tseng C. J., Kuo J. S., Chai C. Y. Involvement of non-NMDA receptors in glutamate-induced pressor or depressor responses of the pons and medulla. Clin. Exp. Pharmac. Physiol. 24:1997;46-56.
57. Chen Y. Y., Huang Z. S. Stimulation of locus coeruleus increases arterial pressure in rabbits. Acta Pharmacol. Sin. 18:1997;437-440.
58. Chiang C., Aston-Jones G. Response of locus coeruleus neurons to footshock stimulation is mediated by neurons in the rostral ventral medulla. Neuroscience. 53:1993;705-715.
59. Chieng B., Christie M. J. Lesions to terminals of noradrenergic locus coeruleus neurones do not inhibit opiate withdrawal behaviour in rats. Neurosci. Lett. 186:1995;37-40.
60. Chouvet G., Akoaka H., Aston-Jones G. Serotonin selectively decreases responses of locus coeruleus neurons to glutamate. C. R. Acad. Sci. Paris. 290:1988;D807-D810.
61. Christie M. J., Williams J. T., Osborne P. B., Bellchambers C. E. Where is the locus in opioid withdrawal? Trends Pharmac. Sci. 18:1997;134-140.
62. Chrousos G. P., Gold P. W. The concepts of stress and stress system disorders. J. Am. Med. Assoc. 267:1992;1244-1252.
63. Clement H. W., Gemsa D., Wesemann W. Serotonin-norepinephrine interactions: a voltammetry study on the effect of serotonin receptor stimulation followed in the N. raphe dorsalis and the Locus coeruleus of the rat. J. Neural. Transm. 88:1992;11-23.
64. Collier H. O. J. Cellular site of opiate dependence. Nature. 283:1980;625-629.
65. Conti L. H., Foote S. L. Reciprocal cross-desensitization of locus coeruleus electrophysiological responsivity to corticotropin-releasing factor and stress. Brain Res. 722:1996;19-29.
66. Craig A. D. Spinal and trigeminal lamina 1 input to the locus coeruleus anterogradely labeled with phaseolus vulgaris leucoagglutin (PHA-L) in the cat and monkey. Brain Res. 584:1992;325-328.
67. Craig A. D., Linington A. J., Kniffki K. D. Significant differences in retrograde labeling of spinothalamic tract cells by horseradish peroxidase and the fluorescent tracers fast blue and diamidino yellow. Exp. Brain Res. 74:1989;431-436.
68. Crespi F., Buda M., McRae-Degueurce A., Pujol J. F. Alteration in tyrosine hydroxylase activity in the LC after administration of p-chlorophenylalanine. Brain Res. 19:1980;501-509.
69. Curet O., Dennis T., Scatton B. The formation of deaminated metabolites of dopamine in the locus coeruleus depends upon noradrenergic neuronal activity. Brain Res. 335:1985;297-301.
70. Curtis A. L., Drolet G., Valentino R. J. Hemodynamic stress activates locus coeruleus neurons of unanaesthetized rats. Brain Res. Bull. 31:1993;737-744.
71. Curtis A. L., Grigoriadis D. E., Page M. E., Rivier J., Valentino R. J. Pharmacological comparison of two corticotropin-releasing factor antagonists: in vivo and in vitro studies. J. Pharmac. Exp. Ther. 268:1994;359-365.
72. Curtis A. L., Lechner S. M., Pavcovich L. A., Valentino R. J. Activation of the locus coeruleus noradrenergic system by intracoerulear microinfusion of corticotropin-releasing factor: effects on discharge rate, cortical norepinephrine levels and cortical electroencephalographic activity. J. Pharmac. Exp. Ther. 281:1997;163-172.
73. Dabiré H. Central 5-hydroxytryptamine (5-HT) receptors in blood pressure regulation. Therapie. 46:1991;421-429.
74. Dahlström A., Fuxe K. Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain-stem neurons. Acta Physiol. Scand. 62(Suppl. 232):1964;1-55.
75. De Simoni M. G., Gonon F., Buda M., Pujol J. F. Cholinergic control of catechol metabolism in the rat locus coeruleus as studied by in vivo voltammetry. Eur. J. Pharmac. 95:1983;65-70.
76. De Souza E. B., Insel T. R., Perrin M. H., Rivier J., Vale W. W., Kuhar M. J. Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: an autoradiographic study. J. Neurosci. 5:1985;3189-3203.
77. 3H]dopamine release from nucleus accumbens slices and monoamine levels in a rat model for attention-deficit hyperactivity disorder. Neurochem. Res. 20:1995;427-433.
78. Debure L. I., Moyse E., Fevre-Montange M., Hardin H., Belin M. F., Rousset C., Pujol J. F., Weissmann D. Somatotopic organization of tyrosine hydroxylase expression in the rat locus coeruleus: long term effect of RU 24722. Brain Res. 581:1992;19-32.
79. Desvignes C., Robert F., Vachette C., Chouvet G., Cespuglio R., Renaud B., Lambás-Señas L. Monitoring nitric oxide (NO) in rat locus coeruleus: differential effects of NO synthase inhibitors. NeuroReport. 8:1997;1321-1325.
80. Dietl H., Eisert A., Kraus A., Philippu A. The release of endogenous catecholamines in the cat hypothalamus is affected by spinal transection and drugs which change the arterial blood pressure. J. Auton. Pharmac. 1:1981;279-286.
81. Dietl H., Prast H., Philippu A. Pulsatile release of catecholamines in the hypothalamus of conscious rats. Naunyn-Schmiedeberg's Arch. Pharmac. 347:1993;28-33.
82. Dilts R. P., Boadle-Biber M. C. Differential activation of the 5-hydroxytryptamine-containing neurons of the midbrain raphe of the rat in response to randomly presented inescapable sound. Neurosci. Lett. 199:1995;78-80.
83. Done C., Silverstone P., Sharp T. Effect of naloxone-precipitated morphine withdrawal on noradrenaline release in rat hippocampus in vivo. Eur. J. Pharmac. 215:1992;333-336.
84. Done C. J. G., Sharp T. Biochemical evidence for the regulation of central noradrenergic activity by 5-HT1A and 5-HT2 receptors: microdialysis studies in the awake and anaesthetized rat. Neuropharmacology. 33:1994;411-421.
85. Duggan S., Hong M., Milne B., Jhamandas K. The role of excitatory amino acids in the expression of precipitated and chronic clonidine withdrawal: an in vivo voltammetric study in the rat locus coeruleus. Brain Res. 665:1994;253-261.
86. Duggan S., Milne B., Loomis C. Use of differential normal pulse voltammetry for the measurement of locus coeruleus catecholaminergic metabolism in an acute anaesthetized rodent model of allodynia: effect of mexiletine. J. Neurosci. Meth. 76:1997;21-28.
87. Elam M., Yao T., Svensson T. H., Thoren P. Regulation of locus coeruleus neurons and splanchnic, sympathetic nerves by cardiovascular afferents. Brain Res. 290:1984;281-287.
88. Elam M., Svensson T. H., Thoren P. Differentiated cardiovascular afferent regulation of locus coeruleus neurons and sympathetic nerves. Brain Res. 358:1985;77-84.
89. Ennis M., Aston-Jones G. Activation of locus coeruleus from nucleus paragigantocellularis: a new excitatory amino acid pathway in brain. J. Neurosci. 8:1988;3644-3657.
90. Ennis M., Aston-Jones G. GABA-mediated inhibition of locus coeruleus from the dorsomedial rostral medulla. J. Neurosci. 9:1989;2973-2981.
91. Erickson J. T., Millhorn D. E. Hypoxia and electrical stimulation of the carotid sinus nerve induce Fos-like immunoreactivity within catecholaminergic and serotoninergic neurons of the rat brainstem. J. Comp. Neurol. 348:1994;161-182.
92. Esler, M. (1995) The sympathetic nervous system and catecholamine release and plasma clearance in normal blood pressure control, in aging, and in hypertension. In: Hypertension: Pathophysiology, Diagnosis, and Management, pp. 755-773. Eds J. H. Laragh and B. M. Brenner. Raven Press, New York.
93. Esler M., Lambert G., Vaz M., Thompson J., Kaye D., Kalff V., Kelly M., Turner A., Jennings G. Central nervous system monoamine neurotransmitter turnover in primary and obesity-related human hypertension. Clin. Exp. Hypertens. 19:1997;577-590.
94. Feng Y. Z., Zhang T., Rockhold R. W., Ho I. K. Increased locus coeruleus glutamate levels are associated with naloxone-precipitated withdrawal from butorphanol in the rat. Neurochem. Res. 20:1995;745-751.
95. Feng Y. Z., Zhang T., Tokuyama S., Zhu H., Rockhold R. W., Ho I. K. μ-and δ-Opioid receptor antagonists precipitate similar withdrawal phenomena in butrophanol and morphine dependence. Neurochem. Res. 21:1996;63-71.
96. Feng Y. Z., Rockhold R. W., Ho I. K. Nor-binaltorphimine precipitates withdrawal and excitatory amino acid release in the locus ceruleus of butorphanol - but not morphine-dependent rats. J. Pharmac. Exp. Ther. 283:1997;932-938.
97. Fillenz, M. (1990) Noradrenergic Neurons. Cambridge University Press, Cambridge.
98. Fillenz M. Physiological release of excitatory amino acids. Behav. Brain Res. 71:1995;51-67.
99. Finlay, J. M. and Zigmond, M. K. (1995) A critical analysis of neurochemical methods for monitoring transmitter dynamics in the brain. In: Psychopharmacology: The Fourth Generation of Progress, pp. 29-40. Eds F. E. Bloom and D. J. Kupfer. Raven Press, New York.
100. Fischer H., Prast H., Philippu A. Adenosine release in the ventral striatum of the rat is modulated by endogenous nitric oxide. Eur. J. Pharmac. 275:1995;R5-R6.
101. Foote S. L., Bloom F. E., Aston-Jones G. Nucleus locus ceruleus: new evidence of anatomical and physiological specificity. Physiol. Rev. 63:1983;844-914.
102. Gardner E. L., Chen J., Peredes W. Overview of chemical sampling techniques. J. Neurosci. Methods. 48:1993;173-197.
103. Gerhardt G. A., Oke A. F., Nagy G., Moghaddam B., Adams R. N. Nafion-coated electrodes with high selectivity for CNS electrochemistry. Brain Res. 290:1984;390-394.
104. Goddard A. W., Charney D. S. Toward an integrated neurobiology of panic disorder. J. Clin. Psychiat. 58:1997;4-11.
105. Goddard, A. W., Woods, S. W. and Charney, D. S. (1996). A critical review of the role of norepinephrine in panic disorder: focus on its interaction with serotonin. In Advances in the Neurobiology of Anxiety Disorders, pp. 107-137. Eds H. G. M. Westenberg, J. A. Den Boer and D. L. Murphy. Wiley, Chichester.
106. Gonon F., Buda M., De Simoni G., Pujol J.-F. Catecholamine metabolism in the rat locus coeruleus as studies by in vivo differential pulse voltammetry. II. pharmacological and behavioral study. Brain Res. 273:1983;207-216.
107. Gonon F. G., Fombarlet C. M., Buda M. J., Pujol J. F. Electrochemical pretreatment of pyrolytic carbon fiber electrodes. Analyt. Chem. 53:1981;1386-1389.
108. Groves P. M., Wilson C. J. Monoaminergic presynaptic axons and dendrites in rat locus coeruleus seen in reconstructions of serial sections. J. Comp. Neurol. 193:1980;853-862.
109. Gurtu S., Pant K. K., Sinha J. N., Bhargawa K. P. An investigation into the mechanism of cardiovascular responses elicited by electrical stimulation of locus coeruleus and subcoeruleus in the cat. Brain Res. 301:1984;59-64.
110. Haddjeri N., De Montigny C., Blier P. Modulation of the firing activity of noradrenergic neurones in the rat locus coeruleus by the 5-hydroxytryptamine system. Br. J. Pharmac. 120:1997;865-875.
111. Hajos M., Engberg G. A role of excitatory amino acids in the activation of locus coeruleus neurons following cutaneous thermal stimuli. Brain Res. 521:1990;325-328.
112. Hall S., Milne B., Jhamandas K. Nitric oxide synthase inhibitors attenuate acute and chronic morphine withdrawal response in rat locus coeruleus: an in vivo voltammetric study. Brain Res. 739:1996;182-191.
113. Heal, D. J. and Marsden, C. A. (1990) The Pharmacology of Noradrenaline in the Central Nervous System. Oxford Medical Publications, Oxford.
114. Henle, J. (1868) Handbuch der systematischen Anatomie, Vol. 3, Handbuch der Nervenlehre des Menschen. Vieweg und Sohn, Braunschweig.
115. Herbert H., Saper C. B. Organization of medullary adrenergic and noradrenergic projections to the periaqueductal gray matter in the rat. J. Comp. Neurol. 315:1992;34-52.
116. Hirata H., Aston-Jones G. A novel long-latency response of locus coeruleus neurons to noxious stimuli: mediation by peripheral C-fibers. J. Neurophysiol. 71:1994;1752-1761.
117. Hjorth S., Sharp T. Effect of the 5-HT1A receptor agonist 8-OH-DPAT on the release of 5-HT in dorsal and median raphe-innervated rat brain regions as measured by in vivo microdialysis. Life Sci. 48:1991;1779-1786.
118. Hong M., Milne B., Loomis C. W., Jhamandas K. In vivo catechol activity in rat locus coeruleus following different nociceptive stimuli and naloxone. Can. J. Physiol. Pharmac. 70:1992;1082-1089.
119. Hong M., Milne B., Jhamandas K. Evidence for the involvement of excitatory amino acid pathways in the development of precipitated withdrawal from acute and chronic morphine: an in vivo voltrammetric study in the rat locus coeruleus. Brain Res. 623:1993;131-141.
120. Hoshi K., Ma T., Ho I. K. Precipitated K-opioid receptor agonist withdrawal increases glutamate in rat locus coeruleus. Eur. J. Pharmac. 314:1996;301-306.
121. Hoshi K., Ma T., Oh S., Ho I. K. Increased release of excitatory amino acids in rat locus coeruleus in K-opioid agonist dependent rats precipitated by nor-binaltorphimine. Brain Res. 753:1997;63-68.
122. 2 imidazoline ligand, RS 45041, potentiates hyperalgesia in acute arthritis. NeuroReport. 7:1996;1497-1501.
123. Iijima K. Chemocytoarchitecture of the rat locus ceruleus. Histol. Histopathol. 8:1993;581-591.
124. Iijima K., Ohtomo K. Immunocytochemical study using a GABA antiserum for the demonstration of inhibitory neurons in the rat locus coeruleus. Am. J. Anat. 181:1988;43-52.
125. 2-adrenoceptors increases opioid μ-receptor-mediated inhibition of the firing rate of rat locus coeruleus neurones. Naunyn-Schmiedeberg's Arch. Pharmac. 342:1990;490-496.
126. Imai H., Steindler D. A., Kitai S. T. The organization of divergent axonal projections from the midbrain raphe nuclei in the rat. J. Comp. Neurol. 243:1986;363-380.
127. Ito A., Schanberg S. M. Central nervous system mechanisms responsible for blood pressure elevation induced by p-chlorophenylalanine. J. Pharmac. Exp. Ther. 181:1972;65-74.
128. Ivanov A., Aston-Jones G. Extranuclear dendrites of locus coeruleus neurons: activation by glutamate and modulation of activity by alpha adrenoceptors. J. Neurophysiol. 74:1995;2427-2436.
129. Jacobs, B. L. and Fornal, C. A. (1995) Serotonin and behaviour: a general hypothesis. In: Psychopharmacology: The Fourth Generation of Progress, pp. 461-469. Eds F. E. Bloom and D. J. Kupfer. Raven Press, New York.
130. Javelle N., Renaud B., Lambas-Senas L. Monoamine metabolism in the locus coeruleus measured concurrently with behavior during opiate withdrawal: an in vivo microdialysis study in freely moving rats. J. Neurochem. 68:1997;683-690.
131. Jodo E., Aston-Jones G. Activation of locus coeruleus by prefrontal cortex is mediated by excitatory amino acid inputs. Brain Res. 768:1997;327-332.
132. Johnson M. D., Ma P. M. Localization of NADPH-diaphorase activity in monoaminergic neurons of the rat brain. J. Comp. Neurol. 332:1993;391-406.
133. Jones S. L., Gebhart G. F. Inhibition of spinal nociceptive transmission from the midbrain, pons and medulla in the rat: activation of descending inhibition by morphine, glutamate and electrical stimulation. Brain Res. 460:1988;281-296.
134. Jorm C. M., Stamford J. A. Actions of the hypnotic anaesthetic, dexmedetomidine, on noradrenaline release and cell firing in rat locus coeruleus slices. Br. J. Anaest. 71:1993;447-449.
135. Jorm C. M., Stamford J. A. Actions of morphine on noradrenaline efflux in the rat locus coeruleus are mediated via both opioid and α2 adrenoceptor mechanisms. Br. J. Anaest. 74:1995;73-78.
136. Joseph M. H. Can voltammetric electrodes measure brain extracellular dopamine in the behaving animal? Commentary on Blaha and Phillips', "A critical assessment of electrochemical procedures applied to the measurement of dopamine and its metabolites during drug-induced and species - typical behaviours" Behav. Pharmac. 7:1996;709-713.
137. Kachidian P., Astier B., Renaud B., Bosler O. Adrenergic innervation of noradrenergic locus coeruleus neurons. A dual labeling immunocytochemical study in the rat. Neurosci. Lett. 109:1990;23-29.
138. Kaehler S. T., Singewald N., Philippu A. MAO inhibition: effects on basal and stimulus-induced serotonin and 5-hydroxyindole acetic acid release in the locus coeruleus of conscious rats. Naunyn-Schmiedeberg's Arch. Pharmac. 355:1997;R132.
139. Kaehler, S. T., Philippu, A. and Singewald, N. (1998a) Effects of local MAO inhibition on serotonergic transmission during stress, cardiovascular and noxious stimuli. Submitted.
140. Kaehler, S. T., Philippu, A., Kouvelas, D. and Singewald, N. (1998b) Chemoreceptor activation enhances the release of noradrenaline in the locus coeruleus. Submitted.
141. Kawasaki S., Takeda K., Tanaka M., Itoh H., Hirata M., Nakata T., Hayashi J., Oguro M., Sasaki S., Nakagawa M. Enhanced norepinephrine release in hypothalamus from locus coeruleus in SHR. Jpn. Heart J. 32:1991;255-262.
142. Kimes A. S., Vaupel D. B., London E. D. Attenuation of some signs of opioid withdrawal by inhibitors of nitric oxide synthase. Psychopharmacology. 112:1993;521-524.
143. Koda L. Y., Aston-Jones G., Bloom F. E. Small granular vesicles in the locus coeruleus may indicate dendritic release of norepinephrine. Soc. Neurosci. Abstr. 6:1980;446.
144. Koepchen, H. P. (1972) Kreislaufregulation. In: Physiologie des Menschen, Vol. 3, pp. 327-406. Eds. O. H. Gauer, K. Kramer and R. Jung. Urban & Schanzenberg, München.
145. Korf J., Aghajanian G. K., Roth R. H. Increased turnover of norepinephrine in the rat cerebral cortex during stress: role of the locus coeruleus. Neuropharmacology. 12:1973;933-938.
146. Kostopoulos G. K. The tottering mouse: a critical review of its usefulness in the study of the neuronal mechanisms underlying epilepsy. J. Neural. Transm. 35:1992;21-36.
147. Lambas-Senas L., Chamba G., Fety R., Renaud B. Comparative responses of the central adrenaline- and noradrenaline-containing neurons after reserpine injections. Biochem. Pharmac. 35:1986;2207-2211.
148. Lambas-Senas L., Vachette C., Robert F., Ortemann C., Renaud B. In vivo voltammetry and microdialysis monitoring of monoamine metabolism in the rat brainstem neurons. Clin. Exp. Hypertens. 17:1995;129-140.
149. Lambert G. W., Ferrier C., Kaye D. M., Kalff V., Kelly M. J., Cox H. S., Turner A. G., Jennings G. L., Esler M. D. Monoaminergic neuronal activity in subcortical brain regions in essential hypertension. Blood Press. 3:1994;55-66.
150. Lanzinger I., Kobilanski C., Philippu A. Pattern of catecholamine release in the nucleus tractus solitarii of the cat. Naunyn-Schmiedeberg's Arch. Pharmac. 339:1989;298-301.
151. Laverty R., Roth R. H. Clonidine reverses the increased norepinephrine turnover during morphine withdrawal in rats. Brain Res. 182:1980;482-485.
152. Léger L., Descarries L. Serotonin nerve terminals in the locus coeruleus of adult rat: a radioautographic study. Brain Res. 145:1978;1-13.
153. Léger L., Wiklund L., Descarries L., Persson M. Description of an indolaminergic cell component in the cat locus coeruleus: a fluorescence histochemical and radioautographic study. Brain Res. 168:1979;43-56.
154. Lestienne R., Herve-Minvielle A., Robinson D., Briois L., Sara S. J. Slow oscillations as a probe of the dynamics of the locus coeruleus-frontal cortex interaction in anaesthetized rats. J. Physiol. Paris. 91:1997;273-284.
155. Loughlin S. E., Foote S. L., Bloom F. E. Efferent projections of nucleus locus coeruleus: topographic organization of cells of origin demonstrated by three-dimensional reconstruction. Neuroscience. 18:1986;291-306.
156. Lovick T. A. Integrated activity of cardiovascular and pain regulatory systems: role in adaptive behavioural responses. Prog. Neurobiol. 40:1993;631-644.
157. Luppi P. H., Charlety P. J., Fort P., Akaoka H., Chouvet G., Jouvet M. Anatomical and electrophysiological evidence for a glycinergic inhibitory innervation of the rat locus coeruleus. Neurosci. Lett. 128:1991;33-36.
158. Luppi P.-H., Aston-Jones G., Akoaka H., Chouvet G., Jouvet M. Afferent projections to the rat locus coeruleus demonstrated by retrograde and anterograde tracing with cholera-toxin B subunit and phaseolus vulgaris leucoagglutinin. Neuroscience. 65:1995;119-160.
159. 2 adrenergic receptor binding in the locus coeruleus of the spontaneously hypertensive rat. Neurosci. Lett. 131:1991;163-166.
160. 2-adrenoceptors in the central nervous system. J. Physiol. Pharmac. 46:1995;241-258.
161. Maeda T., Kojima Y., Arai M., Fujimiya M., Kimura H., Kitahama K., Geffard M. Monoaminergic interaction in the central nervous system: a morphological analysis in the locus coeruleus of the rat. Comp. Biochem. Physiol. 98C:1991;193-202.
162. Maldonado R. Participation of noradrenergic pathways in the expression of opiate withdrawal: biochemical and pharmacological evidence. Neurosci. Biobehav. Rev. 21:1997;91-104.
163. Maldonado R., Koob G. F. Destruction of the locus coeruleus decreases physical signs of opiate withdrawal. Brain Res. 605:1993;128-138.
164. Manaye K. F., McIntire D. D., Mann D. M., German D. C. Locus coeruleus cell loss in the aging human brain: a non-random process. J. Comp. Neurol. 358:1995;79-87.
165. Margalit D., Segal M. H. A pharmacologic study of analgesia produced by stimulation of the nucleus locus coeruleus. Psychopharmacology. 62:1979;169-173.
166. Marwaha J., Aghajanian G. K. Relative potencies of alpha-1 and alpha-2 antagonists in the locus coeruleus, dorsal raphe and dorsal lateral geniculate nuclei: an electrophysiological study. J. Pharmac. Exp. Ther. 222:1982;287-293.
167. Maruyama S. Inhibition by topically applied clonidine and guanfacine of the pressor response to stimulation of the locus coeruleus in cats. Jap. J. Pharmac. 31:1981;856-859.
168. Matsumoto M., Yoshioka M., Togashi H., Tochihara M., Ikeda T., Saito H. Modulation of norepinephrine release by serotonergic receptors in the rat hippocampus as measured by in vivo microdialysis. J. Pharmac. Exp. Ther. 272:1995;1044-1051.
169. 2 receptors in the central regulation of the cardiovascular system. Pharmac. Rev. 46:1994;231-243.
170. McKitrick D. J., Krukoff T. L., Calaresu F. R. Expression of c-fos protein in rat brain after electrical stimulation of the aortic depressor nerve. Brain Res. 599:1992;215-222.
171. Melia K. M., Duman R. Involvement of corticotropin-releasing factor in chronic stress regulation of the brain noradrenergic system. Proc. Natl Acad. Sci. U.S.A. 88:1991;8382-8386.
172. Miachon S., Berod A., Leger L., Chat M., Hartman B., Pujol J. F. Identification of catecholamine cell bodies in the pons and pons-mesencephalon junction of the cat brain, using tyrosine hydroxylase and dopamine-β-hydroxylase immunohistochemistry. Brain Res. 305:1984;369-374.
173. Milne B., Quintin L., Gillon J. Y., Pujol J.-F. Fentanyl decrease catecholamine metabolism measured by in vivo voltammetry in the rat locus coeruleus. Can. J. Physiol. Pharmac. 67:1989;532-536.
174. Milne B., Duggan S., Jhamandas K., Loomis C. Innocuous hair deflection evokes a nociceptive-like activation of catechol oxidation in rat locus coeruleus following intrathecal strychnine: a biochemical index of allodynia using in vivo voltammetry. Brain. Res. 718:1996;198-202.
175. Milner T. A., Abate C., Reis D. J., Pickel V. M. Ultrastructural localization of phenylethanolamine N-methyltransferase-like immunoreactivity in the rat locus coeruleus. Brain Res. 478:1989;1-15.
176. Mingazzini, G. (1928) Medulla oblongata und Brücke. In: Handbuch der mikroskopischen Anatomie des Menschen, pp. 579-673. Ed. W. v. Möllendorff. Springer, Berlin.
177. Miyawaki T., Kawamura H., Komatsu K., Yasugi T. Chemical stimulation of the locus coeruleus: inhibitory effects on hemodynamics and renal sympathetic nerve activity. Brain Res. 568:1991;101-108.
178. Moghaddam B. Stress preferentially increases extraneuronal levels of excitatory amino acids in the prefrontal cortex: comparison to hippocampus and basal ganglia. J. Neurochem. 60:1993;1650-1657.
179. Mongeau R., de Montigny C., Blier P. Activation of 5-HT3 receptors enhances the electrically evoked release of [3H]noradrenaline in the rat brain limbic structures. Eur. J. Pharmac. 256:1994;269-279.
180. Montagne-Clavel J., Oliveras J. L., Martin G. Single-unit recordings at dorsal raphe nucleus in the awake-anesthetized rat: spontaneous activity and responses to cutaneous innocuous and noxious stimulations. Pain. 60:1995;303-310.
181. Montague P. R., Gancayco C. D., Winn M. J., Marchase R. B., Friedlander M. J. Role of NO production in NMDA receptor-mediated neurotransmitter release in cerebral cortex. Science. 263:1994;973-977.
182. Morgane P. J., Jacobs M. S. Raphe projections to the locus coeruleus in the rat. Brain Res. Bull. 4:1979;519-534.
183. Mugnaini, E. and Oertel, W. H. (1985) An atlas of the distribution of GABAergic neurons and terminals in the rat CNS as revealed by GAD immunohistochemistry. In: GABA and Neuropeptides in the CNS, pp. 436-608. Eds. A. Björklund and T. Hökfelt, Handbook of Chemical Neuroanatomy, Vol. 4. Elsevier Science, Amsterdam.
184. Murase S., Inui K., Nosaka S. Baroreceptor inhibition of the locus coeruleus noradrenergic neurons. Neuroscience. 61:1994;635-643.
185. Myers R. D., Adell A., Lankford M. F. Simultaneous comparison of cerebral dialysis and push-pull perfusion in the brain of rats: a critical review. Neurosci. Biobehav. Rev. 22:1998;371-387.
186. Nakamura S., Sakaguchi T. Development and plasticity of the locus coeruleus: a review of recent physiological and pharmacological experimentation. Prog. Neurobiol. 34:1990;505-526.
187. Nestler E. J. Cellular responses to chronic treatment with drugs of abuse. Crit. Rev. Neurobiol. 7:1993;23-39.
188. Nicholas A. P., Hökfelt T., Pieribone V. A. The distribution and significance of CNS adrenoceptors examined with in situ hybridization. Trends Pharmac. Sci. 17:1996;245-255.
189. Nitz D., Siegel J. M. GABA release in the locus coeruleus as a function of sleep/wake state. Neuroscience. 78:1997;795-801.
190. 2-autoreceptors in slices of rat locus coeruleus. Naunyn-Schmiedeberg's Arch. Pharmac. 356:1997;159-165.
191. Ogawa M. Interaction between noradrenergic and serotonergic mechanisms on the central regulation of blood pressure in the rat: a study using experimental central hypertension produced by chemical lesions of the locus coeruleus. Jpn. Circ. J. 42:1978;581-597.
192. Okuyama S., Yamada S., Ogawa S., Kawashima N., Tomisawa K., Shima K., Kamata K. Effect of VA-045 on central noradrenergic neuronal system in rats. Gen. Pharmac. 27:1996;1013-1017.
193. Ordway G. A., Stockmeier C. A., Cason G. W., Klimek V. Pharmacology and distribution of norepinephrine transporters in the human locus coeruleus and raphe nuclei. J. Neurosci. 17:1997;1710-1719.
194. Ornstein K., Milon H., McRae-Deguerce A., Alvarez C., Berger B., Wurzner H. P. Biochemical and radioautographic evidence for dopaminergic afferents of the locus coeruleus originating in the ventral tegmental area. J. Neural. Transm. 70:1987;183-191.
195. Ortemann C., Robert F., Renaud B., Lambas-Senas L. In vivo microdialysis study of the extracellular 3,4-dihydroxyphenylacetic acid in the rat locus ceruleus: topographical and pharmacological aspects. J. Neurochem. 61:1993;594-601.
196. Ota M., Mefford I. N., Naoi M., Linnoila M. Effects of morphine administration on catecholamine levels in rat brain; specific reduction of epinephrine concentration in hypothalamus. Neurosci. Lett. 121:1991;129-132.
197. Palij P., Stamford J. A. Real-time monitoring of endogenous noradrenaline release in rat brain slices using fast cyclic voltammetry: 3. Selective detection of noradrenaline efflux in the locus coeruleus. Brain Res. 634:1994;275-282.
198. Palkovits M., Brownstein M., Saavedra J. M. Serotonin content of the brain stem nuclei in the rat. Brain Res. 80:1974;237-249.
199. Pavcovich L. A., Ramirez O. A. Time course effects of uncontrollable stress in locus coeruleus neuronal activity. Brain Res. Bull. 26:1991;17-21.
200. Peyron C., Luppi P. H., Rampon C., Jouvet M. Localization of the GABA-ergic neurons projecting to the rat dorsal raphe and locus coeruleus. Soc. Neurosci. Abstr. 21:1995;373.
201. Philippu A. Involvement of hypothalamic catecholamines in the regulation of the arterial blood pressure. Trends Pharmac. Sci. 1:1980;376-378.
202. Philippu, A. (1984) Use of push-pull cannulae to determine the release of endogenous neurotransmitters in distinct brain areas of anaesthetized and freely moving animals. In: Measurement of Neurotransmitter Release In Vivo, pp. 3-37. Ed. C. A. Marsden. John Wiley, Chichester.
203. Philippu, A. (1985a) The use of push-pull cannulae for superfusing various hypothalamic areas in anaesthetized and conscious, freely moving animals. In: In Vivo Perfusion and Release of Neuroactive Substances. Methods and Strategies, pp. 1-232. Eds. A. Bayon and R. Drucker-Colin. Academic Press, Orlando.
204. Philippu A. Analylsis of hypothalamic transmitter release during cardiovascular changes. Ann. N.Y. Acad. Sci. 472:1985;140-150.
205. Philippu A. Regulation of blood pressure by central neurotransmitters and neuropeptides. Rev. Physiol. Biochem. Pharmac. 111:1988;1-115.
206. Philippu A., Prast H. Ultradian oscillations in the release of catecholamines and histamine in distinct brain areas. Sci. Pharm. 57:1989;265-273.
207. Philippu A., Dietl H., Sinha J. N. In vivo release of endogenous catecholamines in the hypothalamus. Naunyn-Schmiedeberg's Arch. Pharmac. 308:1979;137-142.
208. Philippu A., Dietl H., Sinha J. N. Rise in blood pressure increases the release of endogenous catecholamines in the anterior hypothalamus of the cat. Naunyn-Schmiedeberg's Arch. Pharmac. 310:1980;237-240.
209. Philippu A., Dietl H., Eisert A. Hypotension alters the release of catecholamines in the hypothalamus of the conscious rabbit. Eur. J. Pharmac. 69:1981;519-523.
210. Philippu A., Prast H., Singewald N. Identification and dynamics of neuronal modulation and function in brain structures and nuclei by continuous determination of transmitter release rates using the push-pull superfusion technique: a compelling approach to in vivo brain research. Sci. Pharm. 64:1996;609-618.
211. Pickel V. M., Joh T. H., Reis D. J. A serotonergic innervation of noradrenergic neurons in the nucleus locus coeruleus: demonstration by immunocytochemical localizatio in of the transmitter specific enzymes tyrosine hydroxylase and tryptophan hydroxylase. Brain Res. 131:1977;197-214.
212. Pilowski, P. M., Minson, J. B., Arnolda, L. F. and Chalmers, J. P. (1995) Brain serotonin and hypertension. In: Hypertension: Pathophysiology, Diagnosis, and Management, pp. 775-787. Eds. J. H. Laragh and B. M. Brenner. Raven Press, New York.
213. Pineda J., Kogan J. H., Aghajanian G. K. Nitric oxide and carbon monoxide activate locus coeruleus neurons through a cGMP-dependent protein kinase: involvement of a nonselective cationic channel. J. Neurosci. 16:1996;1389-1399.
214. Pineda J., Ruiz-Ortega J. A., Ugedo L. Receptor reserve and turnover of alpha-2 adrenoceptors that mediate the clonidine-induced inhibition of rat locus coeruleus neurons in vivo. J. Pharmac. Exp. Ther. 281:1997;690-698.
215. Pini A. Effects of capsaicin on conduction in a cutaneous nerve of the rat. J. Physiol. (Lond.). 338:1983;60-61.
216. Prast H., Philippu A. Nitric oxide releases acetylcholine in the basal forebrain. Eur. J. Pharmac. 216:1992;139-140.
217. Prast H., Lamberti C., Fischer H., Tran M. H., Philippu A. Nitric oxide influences the release of histamine and glutamate in the rat hypothalamus. Naunyn-Schmiedeberg's Arch. Pharmac. 354:1996;731-735.
218. Przuntek H., Philippu A. Reduced pressor response to stimulation of the locus coeruleus after lesion of the posterior hypothalamus. Naunyn-Schmiedeberg's Arch. Phramcol. 276:1973;119-122.
219. Quintin L., Hilaire G., Pujol J.-F. Variations in 3,4-dihydroxyphenylacetic acid concentration are correlated to single cell firing changes in the rat locus coeruleus. Neuroscience. 18:1986;889-899.
220. Quintin L., Gonon F., Buda M., Ghignone M., Hilaire G., Pujol J.-F. Clonidine modulates locus coeruleus metabolic hyperactivity induced by stress in behaving rats. Brain Res. 362:1986;366-369.
221. 2-adrenergic tonic inhibition in behaving rats. Brain Res. 375:1986;235-245.
222. 2-adrenergic agonist clonidine to suppress central noradrenergic hyperactivity secondary to hemodynamic or environmental stimuli. J. Card. Pharmac. 10:1987;128-134.
223. Rasmussen K. The role of the locus coeruleus and N-methyl-D-aspartic acid (NMDA) and AMPA receptors in opiate withdrawal. Neuropsychopharmacology. 13:1995;295-300.
224. Rasmussen K., Jacobs B. L. Single unit activity of locus coeruleus neurons in the freely moving cat. II. Conditioning and pharmacologic studies. Brain Res. 371:1986;335-344.
225. Rasmussen K., Aghajanian G. K. Failure to block responses of locus coeruleus neurons to somatosensory stimuli by destruction of two major afferent nuclei. Synapse. 4:1989;162-164.
226. 3H]norepinephrine release from dissociated embryonic locus coeruleus cell cultures. J. Neurochem. 62:1994;1015-1024.
227. Reddy S. V. R., Yaksh T. L. Spinal noradrenergic terminal system mediates antinociception. Brain Res. 189:1980;391-402.
228. Reil J. C. Das verlängerte Rückenmark, die hinteren, seitlichen und vorderen Schenkel des kleinen Gehirns und die theils strangförmig, theils als Ganglienkette in der Axe des Rückenmarks und des Gehirns fortlaufende graue Substanz. Arch. f.d. Physiol. 9:1809;505-514.
229. Renaud B., Buda M., Lewis D., Pujol J. F. Effect of 5,6-dihydroxytryptamine on tyrosine hydroxylase activity in central catecholamine of the rat. Biochem. Pharmac. 24:1975;1739-1742.
230. Robbins, T. W. and Everitt, B. J. (1995) Central norepinephrine neurons and behavior. In: Psycholpharmacology: The Fourth Generation of Progress, pp. 363-372. Eds. F. E. Bloom and D. J. Kupfer. Raven Press, New York.
231. Robert F., Lambas-Senas L., Ortemann C., Pujol J.-F., Renaud B. Microdialysis monitoring of 3,4-dihydroxyphenylalanine accumulation after decarboxylase inhibition: a means to estimate in vivo changes in tyrosine hydroxylase activity of the rat locus ceruleus. J. Neurochem. 60:1993;721-729.
232. Robert F., Ortemann C., Seccia M., Renaud B., Lambas-Senas L. Tyrosine hydroxylase activity in the locus coeruleus of conscious rats: differences with the anesthetized rats. Brain Res. Bull. 34:1994;595-599.
233. Robinson, T. E. and Justice, J. B. (1991) Microdialysis in the Neuroscience. Elsevier Science, Amsterdam.
234. Robinson R. L., Dietl H., Bald M., Kraus A., Philippu A. Effects of short-lasting and long-lasting blood pressure changes on the release of endogenous catecholamines in the hypothalamus of the conscious, freely moving rabbit. Naunyn-Schmiedeberg's Arch. Pharmac. 322:1983;203-209.
235. Rodrigo J., Springall D. R., Uttenthal O., Bentura M. L., Abadia-Molina F., Riveros-Moreno V., Martinez-Murillo R., Polak J. M., Moncada S. Localization of nitric oxide synthase in the adult rat brain. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 345:1994;175-221.
236. Ronken E., Van Muiswinkel F. L., Mulder A. H., Schoffelmeer A. N. M. Opioid receptor-mediated inhibition of evoked catecholamine release from cultered neurons of rat ventral mesencephalon and locus coeruleus. Eur. J. Pharmac. 230:1993;349-355.
237. Ronken E., Mulder A. H., Schoffelmeer A. N. Chronic activation of μ- and kappa-opioid receptors in cultured catecholaminergic neurons from rat brain causes neuronal supersensitivity without receptor desensitization. J. Pharmac. Exp. Ther. 268:1994;595-599.
238. Russel G. V. The nucleus locus coeruleus (dorsalis tegmenti). Tex. Rep. Biol. Med. 13:1955;939-988.
239. Sagen J., Proudfit H. K. Effect of intrathecally administered noradrenergic antagonists on nociception in the rat. Brain Res. 310:1984;295-301.
240. Sagen J., Winker M. A., Proudfit H. K. Hypoalgesia induced by the local injection of phentolamine in the nucleus raphe magnus: blockade by depletion of spinal cord monoamines. Pain. 16:1983;253-263.
241. 1-adrenoceptors. Soc. Neurosci. 12:1986;1391.
242. Sakai K. Physiological properties and afferent connections of the locus coeruleus and adjacent tegmental neurons involved in the generation of paradoxical sleep in the cat. Prog. Brain Res. 88:1991;31-45.
243. Sara S. J., Vankov A., Herve A. Locus coeruleus-evoked responses in behaving rats: a clue to the role of noradrenaline in memory. Brain Res. Bull. 35:1994;457-465.
244. Sawynok J., Reid A. Effect of 6-hydroxydopamine-induced lesions to ascending and descending noradrenergic pathways on morphine analgesia. Brain Res. 419:1987;156-165.
245. Scatton B., Serrano A. GABA mimetics increase extracellular DOPAC (as measured by in vivo voltammetry) in the rat locus coeruleus. Naunyn-Schmiedeberg's Arch. Pharmac. 332:1986;380-383.
246. Schneider C., Singewald N., Philippu A. Inhibition of catecholamine (noradrenaline, dopamine) release in the locus coeruleus and the hypothalamus by baroreceptor activation: identification of the involved baroreceptors. Naunyn-Schmiedeberg's Arch. Pharmac. 352:1995;291-296.
247. Schulz C., Lehnert H. Activation of noradrenergic neurons in the locus coeruleus by corticotropin-releasing factor. A microdialysis study. Neuroendocrinology. 63:1996;454-458.
248. Segal M. Serotonergic innervation of the locus coeruleus from the dorsal raphe and its action on responses to noxious stimuli. J. Physiol. 286:1979;401-415.
249. Sesack S. R., Deutch A. Y., Roth R. H., Bunney B. S. Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with phaseolus vulgaris leucoagglutinin. J. Comp. Neurol. 290:1989;213-242.
250. Sharma S. K., Klee W. A., Nirenberg M. Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc. Natl Acad. Sci. U.S.A. 72:1975;3092-3096.
251. Sharp T., Bramwell S. R., Grahame-Smith D. G. 5-HT1 agonists reduce 5-hydroxytryptamine release in the rat hippocampus in vivo as determined by brain microdialysis. Br. J. Pharmac. 96:1989;283-290.
252. Shiekhattar R., Aston-Jones G. Sensory responsiveness of brain noradrenergic neurons is modulated by endogenous brain serotonin. Brain Res. 623:1993;72-76.
253. Shih C.-D., Chan S. H. H., Chan J. Y. H. Participation of hypothalamic paraventricular nucleus in locus ceruleus-induced baroreflex suppression in rats. Am. J. Physiol. 269:1995;H46-H52.
254. Shimizu N., Katoh Y., Hida T., Satoh K. The fine structural organization of the locus coeruleus in the rat with reference to noradrenaline contents. Exp Brain Res. 37:1979;139-148.
255. Shipley M. T., Fu L., Ennis M., Liu W.-L., Aston-Jones G. Dendrites of locus coeruleus neurons extend preferentially into two pericoerulear zones. J. Comp. Neurol. 365:1996;56-68.
256. Simson P. E., Weiss J. M. Altered activity of the locus coeruleus in an animal model of depression. Neuropsychopharmacology. 1:1988;287-295.
257. Singewald N., Philippu A. Catecholamine release in the locus coeruleus is modified by experimentally induced changes in haemodynamics. Naunyn-Schmiedeberg's Arch. Pharmac. 347:1993;21-27.
258. Singewald N. and Philippu A. (1996a) The significance of amino acid release in central blood pressure regulation and stress. In: Monitoring Molecules in Neuroscience, Proceedings of the 7th International Conference on In Vivo Methods, Eds. Gonzales-Mora, Borges and Mas. Santa Cruz de Tenerife, Spain, pp. 333-334.
259. Singewald N., Philippu A. Involvement of biogenic amines and amino acids in the central regulation of cardiovascular homeostasis. Trends Pharmac. Sci. 17:1996;356-363.
260. Singewald N., Schneider C., Philippu A. Effects of blood pressure changes on the catecholamine release in the locus coeruleus of cats anaesthetized with pentobarbital or chloralose. Naunyn-Schmiedeberg's Arch. Pharmac. 348:1993;242-248.
261. Singewald N., Schneider C., Pfitscher A., Philippu A. In vivo release of catecholamines in the locus coeruleus. Naunyn-Schmiedeberg's Arch. Pharmac. 350:1994;339-345.
262. Singewald N., Schneider C., Philippu A. Effects of neuroactive compounds, noxious and cardiovascular stimuli on the release of amino acids in the rat locus coeruleus. Neurosci. Lett. 180:1994;55-58.
263. Singewald N., Schneider C., Philippu A. Disturbances in blood pressure homeostasis modify GABA release in the locus coeruleus. NeuroReport. 5:1994;1709-1712.
264. Singewald N., Zhou G. Y., Schneider C. Release of excitatory and inhibitory amino acids from the locus coeruleus of conscious rats by cardiovascular stimuli and various forms of acute stress. Brain Res. 704:1995;42-50.
265. Singewald N., Zhou G-Y., Schneider C., Philippu A. Alterations of amino acid outflow in the locus coeruleus of conscious rats by acute stress and baroreceptor activation. Eur. J. Neurosci. 8(Suppl.):1995;67.
266. Singewald N., Kaehler S. T., Hemeida R. A., Zhou G. Y., Philippu A. In vivo interaction of excitatory amino acid and serotonin release in the locus coeruleus of conscious rats. Naunyn-Schmiedeberg's Arch. Pharmac. 353(Suppl.):1996;R103.
267. Singewald N., Zhou G-Y., Chen F., Philippu A. Corticotropin-releasing factor modulates basal and stress-induced excitatory amino acid release in the locus coeruleus of conscious rats. Neurosci. Lett. 204:1996;45-48.
268. Singewald N., Kaehler S. T., Hemeida R., Philippu A. Release of serotonin in the rat locus coeruleus: effects of cardiovascular, stressful and noxious stimuli. Eur. J. Neurosci. 9:1997;556-562.
269. Singewald N., Kouvelas D., Chen F., Philippu A. The release of inhibitory amino acids in the hypothalamus is tonically modified by impulses from aortic baroreceptors as a consequence of blood pressure fluctuations. Naunyn-Schmiedeberg's Arch. Pharmac. 356:1997;348-355.
270. Singewald N., Zhou G. Y., Kaehler S., Philippu A. Response of GABAergic and glutamatergic neurons in the locus coeruleus to baroreceptor activation and pain. J. Auton. Nerv. Syst. 65:1997;105.
271. Singewald, N., Kaehler, S. T. and Philippu, A. (1998a) Noradrenaline release in the locus coeruleus of the conscious rat: effects of drugs, stress and blood pressure changes. Submitted.
272. Singewald N., Kaehler, S. T. and Philippu, A. (1998b) Stress evokes noradrenaline release in somatodendritic- (locus coeruleus) and terminal- (amygdala) regions of noradrenergic neurons: a dual probe push-pull perfusion study. Naunyn-Schmiedeberg's Arch. Pharmac. 357, Suppl. R27.
273. Singewald N., Kaehler S., Hemeida R., Philippu A. Influence of excitatory amino acids on basal and sensory stimulus-induced release of 5-HT in the locus coeruleus. Br. J. Pharmac. 123:1998;746-752.
274. Singewald, N., Kaehler, S. and Philippu, A. (1998d) Nitric oxide modulates the release of serotonin in the locus coeruleus. Naunyn-Schmiedeberg's Arch. Pharmac. in press.
275. Sinha J. N., Dietl H., Philippu A. Effect of a fall of blood pressure on the release of catecholamines in the hypothalamus. Life Sci. 26:1980;1751-1760.
276. Sladek J. R., Walker P. Serotonin-containing neuronal perikarya in the primate locus coeruleus and subcoeruleus. Brain Res. 134:1977;359-366.
277. Smagin G. N., Swiergiel A. H., Dunn A. J. Sodium nitroprusside infusions activate cortical and hypothalamic noradrenergic systems in rats. Neurosci. Res. Commun. 14:1994;85-91.
278. Smagin G. N., Swiergiel A. H., Dunn A. J. Corticotropin-releasing factor administered into the locus coeruleus, but not the parabrachial nucleus, stimulates norepinephrine release in the prefrontal cortex. Brain Res. Bull. 36:1995;71-76.
279. Stamford J. A. Descending control of pain. Br. J. Anaesth. 75:1995;217-227.
280. Stamford J. A., Palij P., Davidson C., Jorm C. M., Millar J. Stimultaneous "real-time" electrochemical and electrophysiological recording in brain slices with a single carbon-fibre microelectrode. J. Neurosci. Meth. 50:1993;279-290.
281. Stanford S. C. Central noradrenergic neurones and stress. Pharmac. Ther. 68:1995;297-342.
282. Steinbusch, H. W. M. (1984) Serotonin-immunoreactive neurons and their projections in the CNS. In: Classical Transmitters and Transmitter Receptors in the CNS, pp. 68-118. Eds. A. Björklund, T. Hökfelt and M. J. Kuhar. Elsevier Science, Amsterdam.
283. Stornetta R. L., Morrison S. F., Ruggiero D. A., Reis D. J. Neurons of rostral ventrolateral medulla mediate somato pressor reflex. Am. J. Physiol. 256:1989;R448-R462.
284. Suaud-Chagny M. F., Cespuglio R., Rivot J. P., Buda M., Gonon F. High sensitivity measurement of brain catechols and indoles in vivo using electrochemically treated carbon-fiber electrodes. J. Neurosci. Meth. 48:1993;241-250.
285. Suh H. H., Fujimoto J. M., Tseng L. L. Differential mechanisms mediating beta-endorphin- and morphine-induced analgesia in mice. Eur. J. Pharmac. 168:1989;61-70.
286. Sutin E. L., Jacobowitz D. M. Neurochemicals in the dorsal pontine tegmentum. Prog. Brain Res. 88:1991;3-14.
287. Sved A. F., Felsten G. Stimulation of the locus coeruleus decreases arterial pressure. Brain Res. 414:1987;119-132.
288. Svensson T. H. Peripheral, autonomic regulation of locus coeruleus noradrenergic neurons in brain: putative implications for psychiatry and psychopharmacology. Psychopharmacology. 92:1987;1-7.
289. Svensson T. H., Thoren P. Brain noradrenergic neurons in the locus coeruleus inhibition by blood volume load through vagal afferents. Brain Res. 172:1979;174-178.
290. Swanson L. W. The locus coeruleus: a cytoarchitectonic, golgi and immunohistochemical study in the albino rat. Brain Res. 110:1976;39-56.
291. Swiergiel A. H., Takahashi L. K., Rubin W. W., Kalin N. H. Antagonism of corticotropin-releasing factor receptors in the locus coeruleus attenuates shock-induced freezing in rats. Brain Res. 587:1992;263-268.
292. Taylor J. R., Elsworth J. D., Garcia E. J., Grant S. J., Roth R. H., Redmond D. E. Clonidine infusions into the locus coeruleus attenuate behavioral and neurochemical changes associated with naloxone-precipitated withdrawal. Psychopharmacology. 96:1988;121-134.
293. Thomas D. N., Post R. M., Pert A. Focal and systemic cocaine differentially affect extracellular norepinephrine in the locus coeruleus, frontal cortex and hippocampus of the anaesthetized rat. Brain Res. 645:1994;135-142.
294. Thrivikraman K. V., Carlson D. E., Gann D. S. Locus coeruleus monoaminergic activity and plasma corticotropin after hemorrhage in cats. Am. J. Physiol. 254:1988;R289-R295.
295. Thrivikraman K. V., Carlson D. E., Gann D. S. Noradrenergic turnover increases in locus coeruleus after hemorrage in cats. Am. J. Physiol. 254:1988;296-301.
296. Thrivikraman K. V., Plotsky P. M., Gann D. S. Alteration of locus coeruleus noradrenergic activity in relation to pituitary secretion after hemorrhage in cats. Neurosci. Lett. 161:1993;85-88.
297. Tibirica E., Mermet C., Feldman J., Gonon F., Bousquet P. Correlation between the inhibitory effects on catecholaminergic ventrolateral medullary neurons and the hypotension evoked by clonidine: a voltammetric approach. J. Pharmac. Exp. Ther. 250:1989;642-647.
298. Timmerman W., Westerink B. H. C. Brain microdialysis of GABA and glutamate: what does it signify? Synapse. 27:1997;242-261.
299. 2+ channel blocker, on naloxone-increased glutamate levels in the locus coeruleus of opioid-dependent rats. Brain Res. 722:1996;212-216.
300. Vachette C., Bourde O., Gillon J.-Y., Pujol J.-F., Renaud B. Decrease in the reactivity of locus coeruleus neurons to hypotension after an increase in their tyrosine hydroxylase content: a subregional in vivo voltammetry study in the rat. Eur. J. Neurosci. 5:1993;261-268.
301. Vachette C., Debure L., Rousset C., Pujol J.-F., Renaud B. Relationship between tyrosine hydroxylase content and noradrenergic cell reactivity to piperoxane: an in vivo voltammetric approach in the rat locus coeruleus. Eur. J. Neurosci. 6:1994;364-373.
302. Vachette C., Nowak L. G., Amouretti X., Renaud B., Bullier J. In vitro study of the catecholaminergic metabolism of locus coeruleus neurones by differential normal pulse voltammetry. J. Neurosci. Meth. 63:1995;103-112.
303. Valentino R. J. Corticotropin-releasing factor: putative neurotransmitter in the noradrenergic nucleus locus coeruleus. Psychopharmacol. Bull. 25:1989;306-311.
304. Valentino R. J., Foote S. L. Corticotropin-releasing factor disrupts sensory responses of brain noradrenergic neurons. Neuroendocrinology. 45:1987;28-36.
305. Valentino R. J., Foote S. L., Aston-Jones G. Corticotropin-releasing factor activates noradrenergic neurones of the locus coeruleus. Brain Res. 270:1983;363-367.
306. Valentino R. J., Page M. E., Curtis A. L. Activation of noradrenergic locus coeruleus neurons by hemodynamic stress is due to local release of corticotropin-releasing factor. Brain Res. 555:1991;25-34.
307. Van Bockstaele E. J., Chan J. Electron microscopic evidence for coexistence of leucine 5-enkephalin and gamma-aminobutyric acid in a subpopulation of axon terminals in the rat locus coeruleus region. Brain Res. 746:1997;171-182.
308. Van Bockstaele E. J., Pieribone V. A., Aston-Jones G. Diverse afferents converge on the nucleus paragigantocellularis in the rat ventrolateral medulla: retrograde and anterograde tracing studies. J. Comp. Neurol. 290:1989;561-584.
309. Van Bockstaele E. J., Chan J., Biswas A. Ultrastructural evidence for convergence of enkephalin and adrenaline-containing axon terminals on common targets and their presynaptic associations in the rat nucleus locus coeruleus. Brain Res. 718:1996;61-75.
310. Van Bockstaele E. J., Colago E. E. O., Valentino R. J. Corticotropin-releasing factor-containing axon terminals synapse onto catecholamine dendrites and may presynaptically modulate other afferents in the rostral pole of the nucleus locus coeruleus in the rat brain. J. Comp. Neurol. 364:1996;523-534.
311. Van Gaalen M., Kawahara H., Kawahara Y., Westerink B. H. C. The locus coeruleus noradrenergic system in the rat brain studied by dual-probe microdialysis. Brain Res. 763:1997;56-62.
312. Versteeg D. H. G., Van der Gugten J., De Jong W., Palkovits M. Regional concentrations of noradrenaline and dopamine in rat brain. Brain Res. 113:1976;563-574.
313. Vertes R. P., Kocsis B. Projections of the dorsal raphe nucleus to the brainstem: PHA-L analysis in the rat. J. Comp. Neurol. 340:1994;11-26.
314. Weiss G. K., Ratner A., Voltura A., Savage D., Lucero K., Castillo N. The effect of two different types of stress on locus coeruleus alpha-2 receptor binding. Brain Res. Bull. 33:1994;219-221.
315. Weiss J. M., Stout J. C., Aaron M. F., Quan N., Owens M. J., Butler P. D., Nemeroff C. B. Depression and anxiety: role of the locus coeruleus and corticotropin-releasing factor. Brain Res. Bull. 35:1994;561-572.
316. Wenzel, J. and Wenzel, C. (1812) De penitiori structura cerebri hominis et brutorum. Cotta, Tübingen.
317. West W. L., Yeomans D. C., Proudfit H. K. The function of noradrenergic neurons in mediating antinociception induced by electrical stimulation of the locus coeruleus in two different sources of Sprague-Dawley rats. Brain Res. 626:1993;127-135.
318. Westerink B. H. C. Brain microdialysis and its application for the study of animal behaviour. Behav. Brain Res. 70:1995;103-124.
319. Wiklund L., Leger L., Persson M. Monoamine cell distribution in the cat brainstem. A fluorescence histochemical study with quantification of indolaminergic and locus coeruleus cell groups. J. Comp. Neurol. 203:1981;613-647.
320. Williams J. T., North R. A., Shefner S. A., Nishi S., Egan T. M. Membrane properties of rat locus coeruleus neurons. Neuroscience. 13:1984;137-156.
321. 2-adrenoceptors which increase potassium conductance in rat locus coeruleus neurones. Neuroscience. 14:1985;95-101.
322. Wu W. C., Chen S. Y., Kuo J. S., Chai C. Y. Glycine produced pressor responses when microinjected in the pressor areas of pons and medulla in cats. J. Auton. Nerv. Syst. 59:1996;1-11.
323. Xu Z. Q., Pieribone V. A., Zhang X., Grillner S., Hökfelt T. A functional role for nitric oxide in locus coeruleus: immunohistochemical and electrophysiological studies. Exp. Brain. Res. 98:1994;75-83.
324. Young A. M. Intracerebral microdialysis in the study of physiology and behaviour. Rev. Neurosci. 4:1993;373-395.
325. Zacharko R. M., Koszycki D., Mendella P. D., Bradwejn J. Behavioural, neurochemical, anatomical and electrophysiological correlates of panic disorder: multiple transmitter interaction and neuropeptide colocalization. Prog. Neurobiol. 47:1995;371-423.
326. Zhang T., Feng Y., Rockhold R. W., Ho I. K. Naloxone-precipitated morphine withdrawal increases pontine glutamate levels in the rat. Life Sci. 55:1994;25-31.
327. Ziehen, Th. (1903) Handbuch der Anatomie des Menschen, Vol. 4, Centralnervensystem. Fischer, Jena.
328. Ziehen, Th. (1934) Handbuch der Anatomie des Menschen, Vol. 4, Centralnervensystem. Fischer, Jena.